Cite

HARVARD Citation

    Moussa, C. et al. (n.d.). Nilotinib increases brain dopamine and lowers CSF tau and oligomeric alpha-Synuclein in Parkinson's disease. Parkinsonism & related disorders. pp. e4-. [Online]. 
  
Back to record